K. Punt

Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe

Walid Habre, Nicola Disma, Katalin Virág et al. · The Lancet Respiratory Medicine · 2017 · 800 citations · Full text

Medicine, Anesthesiology, Pediatrics +8

Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes

Guido Tricot, R. De Bock, A. W. Dekker et al. · British Journal of Haematology · 1984 · 108 citations

Medicine, Hematology, Pharmacotherapy +14

The use of intermediate dose cytosine arabinoside (ID Ara‐C) in the treatment of acute non‐lymphocytic leukaemia in relapse

H. C. van Prooijen, A. W. Dekker, K. Punt · British Journal of Haematology · 1984 · 77 citations

Medicine, Oncology, Pharmacology +14

Thalassemia Minor Associated with Hemoglobin-B2 Heterozygosity. A Family Report

Titus H.J. Huisman, K. Punt, J. D. G. Schaad · Blood · 1961 · 62 citations · Full text

Medicine, Genetics, Hematology +11

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication

Wim H.J. Kruit, K. Punt, S.H. Goey et al. · Cancer · 1994 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17